Google’s parent company Alphabet is diving into the drug discovery game with an artificial intelligence company built on the protein-folding simulation successes achieved at DeepMind. The new ...
Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Isomorphic Labs says its first artificial-intelligence-designed medicines are nearly ready for human testing. What Happened: Isomorphic Labs President ...
The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information ...
Last year, DeepMind produced a stunning advance in scientific research, demonstrating how its artificial intelligence could be used to predict 3D structures of unique proteins in a solution to a ...
Alphabet has created a new subsidiary called Isomorphic Labs that will focus on using AI processes to develop new drugs. An offshoot from Deepmind, another AI subsidiary of Alphabet, the idea for ...
Que.com on MSN
Alphabet vs Amazon: Which AI stock is better in 2026?
By 2026, artificial intelligence is no longer a future trend for mega-cap tech—it’s a core revenue driver. Two of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results